22 March 2022
We’re excited to welcome a 7th flagship, Disease Mechanisms, to the ACvA organisational structure.
We hope Disease Mechanisms, as a name, expresses engagement with Basic Scientists as well as proximity to patients and a closer integration with the broader ACvA community.
To set up this Flagship, we’re looking for EOIs from individuals to join the Disease Mechanisms Flagship Advisory Group.
As an Advisory Committee member, you’ll work with other members and the Co-Directors to clearly map existing strengths, identify key CV Disease Mechanisms priorities, and develop a strategic roadmap relevant to expanding funding opportunities. The Co-Directors of the Flagship will be selected from the Disease Mechanisms Advisory Group.
If you’re interested, please review the Call for Applications and Position Description.
Applications extended until COB Tuesday 19 April 2022.
If you have any questions, please contact Kerry Doyle (kerry.doyle@27.54.85.145/~ozhearto/clone/).